AU2015328676B2 - Controlled release enteric soft capsules of fumarate esters - Google Patents

Controlled release enteric soft capsules of fumarate esters Download PDF

Info

Publication number
AU2015328676B2
AU2015328676B2 AU2015328676A AU2015328676A AU2015328676B2 AU 2015328676 B2 AU2015328676 B2 AU 2015328676B2 AU 2015328676 A AU2015328676 A AU 2015328676A AU 2015328676 A AU2015328676 A AU 2015328676A AU 2015328676 B2 AU2015328676 B2 AU 2015328676B2
Authority
AU
Australia
Prior art keywords
fae
composition
fumarate
weight
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015328676A
Other languages
English (en)
Other versions
AU2015328676A1 (en
Inventor
Sunil AGNIHOTRI
Tatyana Dyakonov
Aqeel A. Fatmi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Banner Life Sciences LLC
Original Assignee
Banner Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/633,164 external-priority patent/US9326965B2/en
Application filed by Banner Life Sciences LLC filed Critical Banner Life Sciences LLC
Publication of AU2015328676A1 publication Critical patent/AU2015328676A1/en
Priority to AU2017204505A priority Critical patent/AU2017204505B2/en
Application granted granted Critical
Publication of AU2015328676B2 publication Critical patent/AU2015328676B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
AU2015328676A 2014-10-08 2015-08-31 Controlled release enteric soft capsules of fumarate esters Ceased AU2015328676B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017204505A AU2017204505B2 (en) 2014-10-08 2017-06-30 Controlled release enteric soft capsules of fumarate esters

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462061185P 2014-10-08 2014-10-08
US62/061,185 2014-10-08
US14/633,164 US9326965B2 (en) 2014-02-28 2015-02-27 Controlled release fumarate esters
PCT/US2015/017893 WO2015130998A1 (fr) 2014-02-28 2015-02-27 Capsules molles entériques à libération contrôlée d'esters de fumarate
AUPCT/US2015/017893 2015-02-27
US14/633,164 2015-02-27
PCT/US2015/047636 WO2016057133A1 (fr) 2014-10-08 2015-08-31 Capsules molles entériques à libération contrôlée d'esters de fumarate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017204505A Division AU2017204505B2 (en) 2014-10-08 2017-06-30 Controlled release enteric soft capsules of fumarate esters

Publications (2)

Publication Number Publication Date
AU2015328676A1 AU2015328676A1 (en) 2017-04-20
AU2015328676B2 true AU2015328676B2 (en) 2017-07-20

Family

ID=55653524

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015328676A Ceased AU2015328676B2 (en) 2014-10-08 2015-08-31 Controlled release enteric soft capsules of fumarate esters
AU2017204505A Ceased AU2017204505B2 (en) 2014-10-08 2017-06-30 Controlled release enteric soft capsules of fumarate esters

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017204505A Ceased AU2017204505B2 (en) 2014-10-08 2017-06-30 Controlled release enteric soft capsules of fumarate esters

Country Status (4)

Country Link
AU (2) AU2015328676B2 (fr)
CA (1) CA2962916C (fr)
IL (1) IL251402A0 (fr)
WO (1) WO2016057133A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2523796T1 (es) 2004-10-08 2014-12-01 Forward Pharma A/S Composición farmacéutica de liberación controlada que comprende éster de ácido fumárico
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
EP3110408B1 (fr) 2014-02-28 2019-01-16 Banner Life Sciences LLC Capsules molles entériques à libération contrôlée d'esters de fumarate
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US10391160B2 (en) 2014-03-14 2019-08-27 Biogen Ma Inc. Dimethyl fumarate and vaccination regimens
MA40985A (fr) 2014-11-17 2017-09-26 Biogen Ma Inc Méthodes de traitement de la sclérose en plaques
WO2021021520A1 (fr) * 2019-07-26 2021-02-04 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Activation de nrf2 pour le traitement du diabète insipide néphrogénique
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115527A1 (en) * 2003-07-17 2006-06-01 Hassan Emadeldin M Controlled release preparation
US20060165778A1 (en) * 2002-10-01 2006-07-27 Hassan Emadeldin M Enteric composition for the manufacture of soft capsule wall
US20090304790A1 (en) * 2004-10-08 2009-12-10 Aditech Pharma Ab Controlled release pharmaceutical compositions comprising a fumaric acid ester
US20100324327A1 (en) * 2007-09-13 2010-12-23 Kyungpook National University Industry Academic Cooperation Foundation Novel use of dimethylfumarate
US20130216615A1 (en) * 2012-02-07 2013-08-22 David Goldman Pharmaceutical Compositions Containing Dimethyl Fumarate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721099C2 (de) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
US20080299196A1 (en) * 2005-10-07 2008-12-04 Aditech Pharma Ab Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
EP3110408B1 (fr) * 2014-02-28 2019-01-16 Banner Life Sciences LLC Capsules molles entériques à libération contrôlée d'esters de fumarate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165778A1 (en) * 2002-10-01 2006-07-27 Hassan Emadeldin M Enteric composition for the manufacture of soft capsule wall
US20060115527A1 (en) * 2003-07-17 2006-06-01 Hassan Emadeldin M Controlled release preparation
US20090304790A1 (en) * 2004-10-08 2009-12-10 Aditech Pharma Ab Controlled release pharmaceutical compositions comprising a fumaric acid ester
US20100324327A1 (en) * 2007-09-13 2010-12-23 Kyungpook National University Industry Academic Cooperation Foundation Novel use of dimethylfumarate
US20130216615A1 (en) * 2012-02-07 2013-08-22 David Goldman Pharmaceutical Compositions Containing Dimethyl Fumarate

Also Published As

Publication number Publication date
AU2017204505A1 (en) 2017-07-20
AU2015328676A1 (en) 2017-04-20
IL251402A0 (en) 2017-05-29
CA2962916A1 (fr) 2016-04-14
CA2962916C (fr) 2021-06-15
AU2017204505B2 (en) 2018-08-02
WO2016057133A1 (fr) 2016-04-14

Similar Documents

Publication Publication Date Title
US10918616B2 (en) Fumarate ester pharmaceutical compositions
US10918617B2 (en) Fumarate ester pharmaceutical compositions
AU2017204505B2 (en) Controlled release enteric soft capsules of fumarate esters
US11590095B2 (en) Fumarate ester dosage forms
WO2017040272A1 (fr) Formes posologiques d'ester de fumarate
WO2017151184A1 (fr) Formes posologiques d'ester de fumarate

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired